Hun-Sik Wang
Chief Executive Officer bei GL PHARM TECH CORP.
Vermögen: 1 Mio $ am 31.03.2024
Profil
Hun-Sik Wang is currently the Chief Executive Officer and Director at GL Pharm Tech Corp.
Prior to this, he was the Chief Executive Officer at GL PharmTech, Inc. and Co-Chief Executive Officer at Crown Pharm Co., Ltd.
He holds a doctorate degree from Chungnam National University and a graduate degree from Chung-Ang University.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
GL PHARM TECH CORP.
1,30% | 06.03.2024 | 993 323 ( 1,30% ) | 1 Mio $ | 31.03.2024 |
Aktive Positionen von Hun-Sik Wang
Unternehmen | Position | Beginn |
---|---|---|
GL PHARM TECH CORP. | Chief Executive Officer | 01.08.2002 |
Ehemalige bekannte Positionen von Hun-Sik Wang
Unternehmen | Position | Ende |
---|---|---|
Crown Pharm Co., Ltd.
Crown Pharm Co., Ltd. Pharmaceuticals: OtherHealth Technology Crown Pharm Co., Ltd. manufactures medicine and other related products. Its products include Sexcon, Haisoming A, Ganeca, Denti F, Traming, entas, Smer, Alpina, Muspan, Mg-pherol, Picolax, Glutase, and Cragel. The company was founded on February 9, 1985 and is headquartered in Anyang, South Korea. | Chief Executive Officer | - |
GL PharmTech, Inc. /Old/
GL PharmTech, Inc. /Old/ Pharmaceuticals: MajorHealth Technology GL PharmTech, Inc. develops and manufactures new drugs and pharmaceuticals. Its products include incrementally modified and generic drugs and Artemisia leaf extract tablets. The company was founded in August 2002 and is headquartered in Seongnam, South Korea. | Chief Executive Officer | - |
Ausbildung von Hun-Sik Wang
Chungnam National University | Doctorate Degree |
Chung-Ang University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
GL PharmTech, Inc. /Old/
GL PharmTech, Inc. /Old/ Pharmaceuticals: MajorHealth Technology GL PharmTech, Inc. develops and manufactures new drugs and pharmaceuticals. Its products include incrementally modified and generic drugs and Artemisia leaf extract tablets. The company was founded in August 2002 and is headquartered in Seongnam, South Korea. | Health Technology |
GL Pharm Tech Corp. | |
Crown Pharm Co., Ltd.
Crown Pharm Co., Ltd. Pharmaceuticals: OtherHealth Technology Crown Pharm Co., Ltd. manufactures medicine and other related products. Its products include Sexcon, Haisoming A, Ganeca, Denti F, Traming, entas, Smer, Alpina, Muspan, Mg-pherol, Picolax, Glutase, and Cragel. The company was founded on February 9, 1985 and is headquartered in Anyang, South Korea. | Health Technology |